CD47 and neoplasm: In research targeting lung metastasis of OS, MPIRx (a biomimetic nanodrug composed of a sonosensitizer and a CD47 inhibitor) is capable of directing macrophages towards tumor cells, fostering M1 polarization, and enhancing the phagocytic activity of macrophages towards OS cells (119).